IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $219,573,912 | +3.2% | 4,840,695 | -6.7% | 0.21% | +9.9% |
| Q2 2023 | $212,830,961 | +10.4% | 5,187,204 | -3.8% | 0.19% | +4.3% |
| Q1 2023 | $192,695,117 | -6.0% | 5,391,581 | -0.6% | 0.18% | -8.9% |
| Q4 2022 | $204,926,506 | -19.8% | 5,425,642 | -6.0% | 0.20% | -21.7% |
| Q3 2022 | $255,379,000 | +14.9% | 5,773,892 | -3.9% | 0.26% | +24.6% |
| Q2 2022 | $222,335,000 | -7.3% | 6,005,818 | -7.3% | 0.21% | +15.0% |
| Q1 2022 | $239,872,000 | +34.0% | 6,476,033 | +10.1% | 0.18% | +47.5% |
| Q4 2021 | $179,019,000 | -27.2% | 5,882,982 | -19.7% | 0.12% | -30.3% |
| Q3 2021 | $245,758,000 | -9.6% | 7,327,322 | +7.5% | 0.18% | -7.4% |
| Q2 2021 | $271,874,000 | -18.3% | 6,815,601 | -7.9% | 0.19% | -23.8% |
| Q1 2021 | $332,837,000 | -14.9% | 7,402,967 | +7.1% | 0.25% | -17.9% |
| Q4 2020 | $390,982,000 | +13.3% | 6,915,147 | -4.9% | 0.30% | +1.7% |
| Q3 2020 | $345,121,000 | -23.6% | 7,273,365 | -5.1% | 0.30% | -27.2% |
| Q2 2020 | $451,765,000 | +18.9% | 7,662,224 | -4.6% | 0.41% | -1.0% |
| Q1 2020 | $379,860,000 | -21.5% | 8,034,264 | +1.1% | 0.41% | +2.7% |
| Q4 2019 | $483,928,000 | -13.1% | 7,947,576 | -14.5% | 0.40% | -17.5% |
| Q3 2019 | $556,619,000 | -8.9% | 9,290,924 | -2.2% | 0.49% | -8.1% |
| Q2 2019 | $610,696,000 | -20.8% | 9,502,032 | +0.0% | 0.53% | -22.3% |
| Q1 2019 | $770,978,000 | +37.4% | 9,498,310 | -8.5% | 0.68% | +19.9% |
| Q4 2018 | $561,160,000 | +6.3% | 10,380,319 | +1.4% | 0.57% | +25.1% |
| Q3 2018 | $528,021,000 | +17.1% | 10,236,939 | -5.4% | 0.45% | +23.0% |
| Q2 2018 | $450,874,000 | -6.3% | 10,820,120 | -0.9% | 0.37% | -18.7% |
| Q1 2018 | $481,358,000 | -12.9% | 10,920,109 | -0.6% | 0.45% | -11.2% |
| Q4 2017 | $552,536,000 | -4.7% | 10,984,818 | -4.0% | 0.51% | -8.4% |
| Q3 2017 | $580,000,000 | -3.6% | 11,439,851 | -3.3% | 0.56% | -5.6% |
| Q2 2017 | $601,684,000 | +26.1% | 11,827,881 | -0.4% | 0.59% | +23.1% |
| Q1 2017 | $477,302,000 | -17.2% | 11,873,179 | -1.5% | 0.48% | -24.3% |
| Q4 2016 | $576,475,000 | +45.3% | 12,052,583 | +11.3% | 0.63% | +41.8% |
| Q3 2016 | $396,752,000 | +51.2% | 10,828,375 | -3.9% | 0.45% | +44.2% |
| Q2 2016 | $262,411,000 | -41.8% | 11,267,127 | +1.3% | 0.31% | -42.4% |
| Q1 2016 | $450,544,000 | -23.2% | 11,124,548 | +17.4% | 0.54% | -20.8% |
| Q4 2015 | $586,768,000 | – | 9,474,704 | – | 0.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,510,173 | $159,221,447 | 8.52% |
| Bellevue Group AG | 9,233,700 | $418,840,632 | 6.75% |
| Deep Track Capital, LP | 2,834,069 | $128,553,370 | 4.96% |
| BVF INC/IL | 4,004,613 | $181,649,246 | 4.90% |
| Sicart Associates LLC | 203,132 | $9,214,068 | 3.61% |
| Camber Capital Management LP | 2,250,000 | $102,060 | 3.36% |
| Privium Fund Management B.V. | 228,493 | $10,364,443 | 3.08% |
| Orbimed Advisors | 2,169,500 | $98,408,520 | 2.09% |
| SECTOR GAMMA AS | 165,616 | $7,512,342 | 1.92% |
| TANAKA CAPITAL MANAGEMENT INC | 14,612 | $663 | 1.89% |